MDxHealth Q4 2023 GAAP EPS $(0.390) Misses $(0.150) Estimate, Sales $19.398M Beat $18.136M Estimate
MDxHealth Q4 2023 GAAP EPS $(0.390) Misses $(0.150) Estimate, Sales $19.398M Beat $18.136M Estimate
MDxHealth 2023年第四季度GAAP每股收益美元（0.390）未達到預期（0.150），銷售額爲1,9398萬美元，超過預期的1,813.6億美元
MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.390) per share which missed the analyst consensus estimate of $(0.150) by 160 percent. The company reported quarterly sales of $19.398 million which beat the analyst consensus estimate of $18.136 million by 6.96 percent. This is a 50.48 percent increase over sales of $12.891 million the same period last year.
MDxHealth（納斯達克股票代碼：MDXH）公佈的季度虧損爲每股0.390美元，比分析師普遍預期的0.150美元（0.150美元）低160％。該公司公佈的季度銷售額爲1939.8萬美元，比分析師共識估計的1813.6萬美元高出6.96％。這比去年同期的1289.1萬美元的銷售額增長了50.48％。